Good afternoon :)
$
₹
E

Entero Therapeutics, Inc.

GRDX

NASDAQ
E

Entero Therapeutics, Inc.

GRDX

NASDAQ
$5.50—% (+5.50)
$
₹
$5.50—% (+5.50)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Unknown

Sector and industry information not available

Micro Cap

With a market cap of $10.3M the stock is ranked 5695

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.45
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-11.66
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Company Profile

GridAI Technologies Corp. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It serves residential and small business, commercial and utility, technology and innovation, and hyperscale industries. The company is based in Edinburgh, United Kingdom.
GridAI Technologies Corp. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It serves residential and small business, commercial and utility, technology and innovation, and hyperscale industries. The company is based in Edinburgh, United Kingdom.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
GE Vernova LLC
GEV
GE Vernova LLC
P/E Ratio
22.63
22.63
1Y Return
67.56%
67.56%
Buy Reco %
81.57
81.57
Vistra Corp.
VST
Vistra Corp.
P/E Ratio
22.69
22.69
1Y Return
35.23%
35.23%
Buy Reco %
95.65
95.65
Talen Energy Corporation
TLN
T
P/E Ratio
—
—
1Y Return
17.32%
17.32%
Buy Reco %
90.00
90.00
The AES Corporation
AES
The AES Corporation
P/E Ratio
5.58
5.58
1Y Return
11.01%
11.01%
Buy Reco %
0.00
0.00
Compare with Peers

Financials

Financials

Income

Balance Sheet

Cash Flow

Hmm, looks like data is currently unavailable. Once it's updated, you can view it here

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Entero Therapeutics, Inc. -0.45-
GE Vernova LLC22.6319.941.67
Vistra Corp.22.6915.440.39
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare GRDX with any stock or ETF
Compare GRDX with any stock or ETF
Comparing from
GRDX
GEV
VST
Loading...

Frequently asked questions

  1. Entero Therapeutics, Inc. (GRDX) share price today is $5.50 as of November 5, 2026 at 2:29 AM IST. The stock touched a day high of $5.73 and a day low of $4.99.

  2. Entero Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol GRDX.

  3. Entero Therapeutics, Inc.'s market capitalization is $10.28M as of November 5, 2026 at 2:29 AM IST.

  4. Entero Therapeutics, Inc.'s price-to-earnings (P/E) ratio is N/A as of November 4, 2026.

  5. Entero Therapeutics, Inc.'s price-to-book (P/B) ratio is 0.45 as of November 4, 2026.

  6. Yes, You can buy Entero Therapeutics, Inc. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Entero Therapeutics, Inc. shares in three steps: 1. Search Entero Therapeutics, Inc. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Entero Therapeutics, Inc. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Entero Therapeutics, Inc. (GRDX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 1.8165 shares at the current price of $5.50.

Loading...